| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |